Operating Expenses Summary of Doseology Sciences Inc.

Doseology Sciences Inc.'s latest annual operating expenses in 2023 was 72.08 Thousand CAD , down -60.9% from previous year.
Doseology Sciences Inc.'s latest quarterly operating expenses in 2023 Q4 was 125.1 Thousand CAD , up 484.43% from previous quarter.
Doseology Sciences Inc. reported a annual operating expenses of 873.45 Thousand CAD in annual operating expenses 2022, down -47.64% from previous year.
Doseology Sciences Inc. reported a annual operating expenses of 1.66 Million CAD in annual operating expenses 2021, up 6.44% from previous year.
Doseology Sciences Inc. reported a quarterly operating expenses of 21.4 Thousand CAD for 2023 Q3, down -83.74% from previous quarter.
Doseology Sciences Inc. reported a quarterly operating expenses of 113.24 Thousand CAD for 2023 Q1, down -13.42% from previous quarter.

Annual Operating Expenses Chart of Doseology Sciences Inc. (2023 - 2019)

Name	Operating Expenses	Operating Expenses Difference
Algernon Pharmaceuticals Inc.	5.19 Million CAD	98.611%
Asep Medical Holdings Inc	7.74 Million CAD	99.069%
BetterLife Pharma Inc.	3.24 Million CAD	97.775%
BioVaxys Technology Corp.	2.4 Million CAD	97.0%
ChitogenX Inc.	2.83 Million CAD	97.453%
Rapid Dose Therapeutics Corp.	4.2 Million CAD	98.287%
Defence Therapeutics Inc.	12.65 Million CAD	99.43%
Entheon Biomedical Corp.	564.31 Thousand CAD	87.226%
Gemina Laboratories Ltd.	5.08 Million CAD	98.583%
Glow Lifetech Corp.	25.71 Thousand CAD	-180.331%
Lexston Life Sciences Corp.	674.71 Thousand CAD	89.316%
Pharmala Biotech Holdings Inc.	1.21 Million CAD	94.077%
MYND Life Sciences Inc.	1.47 Million CAD	95.112%
Nova Mentis Life Science Corp.	1.2 Million CAD	94.004%
PharmaTher Holdings Ltd.	3.04 Million CAD	97.632%
PreveCeutical Medical Inc.	963.12 Thousand CAD	92.515%
Telescope Innovations Corp.	6.35 Million CAD	98.865%